Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
Want to see IN:SUNPHARMA full AI Analyst Report?
Total Valuation
Sun Pharmaceutical Industries Limited has a market cap or net worth of ₹4.34T. The enterprise value is ₹4.25T.
Market Cap₹4.34T
Enterprise Value₹4.25T
Share Statistics
Sun Pharmaceutical Industries Limited has 2,399,278,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,399,278,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sun Pharmaceutical Industries Limited’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.46%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)11.46%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee13.60M
Profits Per Employee2.67M
Employee Count43,000
Asset Turnover0.54
Inventory Turnover2.25
Valuation Ratios
The current PE Ratio of Sun Pharmaceutical Industries Limited is 37.8. Sun Pharmaceutical Industries Limited’s PEG ratio is 7.62.
PE Ratio37.8
PS Ratio7.22
PB Ratio5.05
Price to Fair Value5.05
Price to FCF45.66
Price to Operating Cash Flow90.81
PEG Ratio7.62
Income Statement
In the last 12 months, Sun Pharmaceutical Industries Limited had revenue of 584.62B and earned 114.79B in profits. Earnings per share was 47.80.
Revenue584.62B
Gross Profit325.62B
Operating Income135.53B
Pretax Income150.63B
Net Income114.79B
EBITDA183.40B
Earnings Per Share (EPS)47.80
Cash Flow
In the last 12 months, operating cash flow was 47.81B and capital expenditures -23.88B, giving a free cash flow of 23.93B billion.
Operating Cash Flow47.81B
Free Cash Flow23.93B
Free Cash Flow per Share9.97
Dividends & Yields
Sun Pharmaceutical Industries Limited pays an annual dividend of ₹5, resulting in a dividend yield of 0.91%
Dividend Per Share₹5
Dividend Yield0.91%
Payout Ratio32.52%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change8.27%
50-Day Moving Average1.78K
200-Day Moving Average1.72K
Relative Strength Index (RSI)50.83
Average Volume (3m)102.58K
Important Dates
Sun Pharmaceutical Industries Limited upcoming earnings date is Jul 30, 2026, TBA (Confirmed).
Last Earnings DateMay 22, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
Sun Pharmaceutical Industries Limited as a current ratio of 2.82, with Debt / Equity ratio of 5.50%
Current Ratio2.82
Quick Ratio2.31
Debt to Market Cap0.01
Net Debt to EBITDA-0.38
Interest Coverage Ratio39.99
Taxes
In the past 12 months, Sun Pharmaceutical Industries Limited has paid 35.54B in taxes.
Income Tax35.54B
Effective Tax Rate0.24
Enterprise Valuation
Sun Pharmaceutical Industries Limited EV to EBITDA ratio is 22.63, with an EV/FCF ratio of 44.90.
EV to Sales7.10
EV to EBITDA22.63
EV to Free Cash Flow44.90
EV to Operating Cash Flow32.29
Balance Sheet
Sun Pharmaceutical Industries Limited has ₹278.80B in cash and marketable securities with ₹52.15B in debt, giving a net cash position of ₹226.65B billion.
Cash & Marketable Securities₹278.80B
Total Debt₹52.15B
Net Cash₹226.65B
Net Cash Per Share₹94.47
Tangible Book Value Per Share₹251.92
Margins
Gross margin is 55.70%, with operating margin of 23.18%, and net profit margin of 19.64%.
Gross Margin55.70%
Operating Margin23.18%
Pretax Margin25.77%
Net Profit Margin19.64%
EBITDA Margin31.37%
EBIT Margin26.35%
Analyst Forecast
The average price target for Sun Pharmaceutical Industries Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.19%
EPS Growth Forecast5.01%